Chun Yen Cheng
About Chun Yen Cheng
Chun Yen Cheng is a Senior Manager of Biostatistics at Bristol Myers Squibb with extensive experience in the pharmaceutical industry and expertise in CDISC Compliance and statistical modeling.
Company
Chun Yen Cheng currently holds the position of Senior Manager, Biostatistics at Bristol Myers Squibb, a leading global biopharmaceutical company. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Chun Yen Cheng is the Senior Manager, Biostatistics at Bristol Myers Squibb. His role entails overseeing statistical methodologies and analyses critical for the design and evaluation of clinical trials.
Education and Expertise
Chun Yen Cheng holds a Master of Science (M.S.) in Statistics from Rutgers University-New Brunswick, completed in 2015. He also earned a Bachelor of Arts (B.A.) in Economics from National Taiwan University in 2011. With specialized expertise in CDISC Compliance, WinNonlin, and statistical modeling, Cheng has applied these skills to ensure precision and accuracy in clinical trials, contributing to standardized data collection and submission in the pharmaceutical industry.
Background
Before his current role at Bristol Myers Squibb, Chun Yen Cheng amassed significant experience in the pharmaceutical industry. He worked as Principal Statistician at Kite Pharma from 2020 to 2021 and held various positions at Firma Clinical Research from 2017 to 2020, including Senior Biostatistician. Cheng also accumulated valuable experience at H2O Clinical, where he served as Biostatistician and Associate Statistician from 2015 to 2017. Additionally, he completed mandatory military service as a Squad Leader with the Ministry of Defense in Taiwan from 2011 to 2012.
Achievements
Chun Yen Cheng has a demonstrated history of contributing to the development and approval of new pharmaceutical products. His advanced skills in statistical analysis and modeling have supported critical decision-making processes in clinical research. Cheng’s work on data analysis projects has been instrumental in the pharmaceutical industry's efforts to deliver effective treatments and therapies.